METHOD FOR PREDICTING THE RISK OF TRANSPLANT REJECTION AND IMMUNOLOGICAL TESTKIT

Details for Australian Patent Application No. 2002312907 (hide)

Owner CELLTREND GMBH

Inventors HEIDECKE, Harald; MULLER, Dominik; WALLUKAT, Gerd; DECHEND, Ralf; DRAGUN, Duska; SCHULZE-FORSTER, Kai

Pub. Number AU-A-2002312907

PCT Number PCT/EP02/05251

PCT Pub. Number WO2002/093171

Priority 101 23 929.7 11.05.01 DE

Filing date 13 May 2002

Wipo publication date 25 November 2002

International Classifications

G01N 033/564 Investigating or analysing materials by specific methods not covered by groups - for pre-existing immune complex or autoimmune disease

G01N 033/566 Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

G01N 033/68 Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

2 January 2003 Complete Application Filed

  Priority application(s): 101 23 929.7 11.05.01 DE

1 May 2003 Application Open to Public Inspection

  Published as AU-A-2002312907

4 March 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002312908-METHOD FOR THE PRODUCTION OF TRIAZOLYLMETHYLEPOXIDES

2002312906-NUCLEIC ACID, WHICH BINDS TO GNRH